Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

selegiline

selegiline
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Eldepryl CAPSULE, ORAL 5 mg      
Emsam FILM, EXTENDED RELEASE, TRANSDERMAL 6 mg/24 hr, 9 mg/24 hr, 12 mg/24 hr      
Zelapar TABLET, DISINTEGRATING, ORAL 1.25 mg    
VIEW MORE Central Nervous System Agents, Miscellaneous
CLASS
289200
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

selegiline (Zelapar)

  • 1.25 mg disintegrating tablet oral

selegiline (Eldepryl)

  • 5 mg capsule oral

Emsam medication guide

Emsam (selegiline patch) is designated as formulary, not generally stocked. If possible, defer initiation to the outpatient setting and encourage the use of the patient's home supply during hospitalization for patients receiving the drug at home. Please note that MAOI dietary restrictions apply to Emsam doses greater than 6 mg/day.

Selegiline ODT (ZELAPAR) is non-formulary, not stocked. If ordered the patient may take his/her own supply or the regimen may be automatically interchanged to regular selegiline. Regular selegiline tablets may be crushed if needed.

Reviewed: May 23, 2006 (Emsam) Reviewed: August 23, 2006 (Zelapar)

Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved